Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.
about
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerSAAG-4 is a novel mosquito salivary protein that programmes host CD4+T cells to express IL-4Heat shock proteins (HSPs) in the homeostasis of regulatory T cells (Tregs)Clients and Oncogenic Roles of Molecular Chaperone gp96/grp94Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells.A novel sphingomyelinase-like enzyme in Ixodes scapularis tick saliva drives host CD4 T cells to express IL-4.Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro.Identification of peptide mimotopes of gp96 using single-chain antibody library.Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenHsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivoHeat-shock protein-based vaccines for cancer and infectious disease.Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice.The stress protein gp96 is not an activator of resting rat bone marrow-derived dendritic cells, but is a costimulator and activator of CD3+ T cells.Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to comeAdministration of the stress protein gp96 prolongs rat cardiac allograft survival, modifies rejection-associated inflammatory events, and induces a state of peripheral T-cell hyporesponsivenessThe heat-shock protein receptors: some answers and more questions.Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccinesImmunotherapy for human cancer using heat shock protein-peptide complexes.Heat shock proteins HSP70 and GP96: structural insights.Heat shock proteins and scavenger receptors: role in adaptive immune responses.Heat shock protein 70: roles in multiple sclerosis.Heat shock protein vaccines: from bench to bedside.Heat-shock protein-peptide complex-96 for the treatment of cancer.Secreted heat shock protein gp96-Ig: an innovative vaccine approach.In vitro and in vivo differentiated effector CD8 T cells display divergent histone acetylation patterns within the Ifng locusVaccine therapy for renal cancer.Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.Blood feeding by the Rocky Mountain spotted fever vector, Dermacentor andersoni, induces interleukin-4 expression by cognate antigen responding CD4+ T cells.Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24.Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease.How to improve the immunogenicity of chemotherapy and radiotherapy.Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases.Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease.Identification of pancreatic cancer-associated tumor antigen from HSP-enriched tumor lysate-pulsed human dendritic cells.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.Targeting Hsp70: A possible therapy for cancer.Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer?
P2860
Q26795466-A2466650-BE61-4A17-B412-8859773B742EQ27489884-5EB78933-90FD-4B0F-8825-3675C27E4DC6Q28069922-E230E69A-35D8-4BC3-B7DF-7FEC490E76BEQ28075479-71035E0B-F629-42CD-9F79-CDB46BA2A64FQ33358420-57B31CC3-B1D1-4BB3-9A20-8CA3F902E1A1Q33418895-8C8A73D9-7C2C-4170-B293-E378B2A29321Q33701133-B38FB1AE-BC01-432C-B775-FDBD0ECB8E8EQ33720789-804B45C2-0983-4C87-AA25-612DE0B41890Q33756678-4253181A-2D51-4CE7-8859-8B3490DBB0FEQ33791226-3FD53571-D3EB-4E9C-A2E0-E3F837605372Q34738862-C4ED6ACB-CCC5-4BBA-8080-EEB91B1FB0A5Q34768299-ECDBBA55-2681-41FE-8854-065776C907DCQ35010256-557325D6-802F-49F4-94EC-D68E5C70B23FQ35239568-C3BEEB3A-90AE-4626-B11D-E89F17E85750Q35624884-23018225-399E-45D3-A661-D650BD18EF05Q35753012-30531729-30BD-455C-A3CE-A8C15A547D67Q35884104-F34454DE-438B-4E83-B30E-A87021E087C1Q36026319-64160ADC-A84A-4B72-B719-FA14ABED490EQ36045961-A4F63580-88B6-4791-AB2A-269C71FC95C9Q36201160-C334E072-E347-4E53-AFDE-6D096DEE4F2EQ36246603-99B5A23B-2DF0-41B0-B087-1DD56DC0F219Q36283450-3B1FDD7A-39E2-477A-A92B-C696AE4D9A55Q36684490-1FC80847-22B1-47F3-B805-DF65F2509476Q36909395-D889031E-4E7C-45D4-B8B6-8BD0AF707655Q37135767-9EB8BAE8-6CF4-4CAC-99C0-E6456840ADA1Q37194984-F1A0ED8A-4479-4636-9D00-F0BBE56F465DQ37259586-EDD7FFB0-853E-4B0A-A28D-5B93592D0449Q37259616-7AB57BDA-EC98-4C95-97DF-0FFA9FCB8212Q37393859-FDF4A7B6-461A-42D3-B1AB-DE3254323979Q37410002-7DF6AD00-B499-4FBA-B3F1-8AB32D32096EQ37412334-2D96F6B9-2774-4D40-9568-FE9D6CA9BCD9Q37707162-50A58BAC-71FA-48B3-9C29-D14839B327CBQ37711797-D90DD1F2-9CD6-423D-9BD6-66BB563CD1DCQ37836489-1F5E228F-A536-4CA7-BD15-BB97B6E510CDQ38164258-736B324D-19D8-43D4-9A86-83439F36BA70Q38325093-0D91EC3F-8684-4BE8-A57C-5BBECE46DE67Q38437145-EE9911A0-C594-4900-971F-82DD3BBC0C48Q38620773-A47EF9CB-3A54-4BFF-B3B9-0C4A484BE35BQ38742944-6EDAB116-6ADE-44AF-B409-875D3293DF05Q39178654-4D8737A8-0AA7-4AC3-AF4D-DE3F59A151E3
P2860
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@ast
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@en
type
label
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@ast
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@en
prefLabel
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@ast
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@en
P2093
P2860
P1476
Glycoprotein 96 can chaperone ...... CD8+ T cell effector function.
@en
P2093
Adam J Adler
Adam T Hagymasi
Amy D H Doody
Charles G Drake
Joseph T Kovalchin
Marianne A Mihalyo
P2860
P304
P356
10.4049/JIMMUNOL.172.10.6087
P407
P577
2004-05-01T00:00:00Z